Title
Category
Credits
Event date
Cost
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will explore how to identify specific injuries and conditions that require early specialist intervention versus those that can be managed conservatively.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will cover the latest research on migraines, including neuroelectric networks, the role of calcitonin gene-related peptide (CGRP) and other neuropeptides, and the underlying mechanisms of migraines.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will focus on the latest approaches to managing elevated lipid profiles, emphasizing the importance of tailoring treatment to individual risk profiles as per the latest American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Delve into the latest trends and research in integrative and complementary alternative medicine (CAM), highlighting the growing body of evidence supporting the efficacy and safety of CAM therapies. Participants will explore specific modalities and learn about their integration into conventional medical practice. The session will emphasize the importance of rigorous research methodologies and the role of CAM in enhancing patient care, driven by increasing patient interest.
  • Behavioral health
  • Disease management
  • Wellness
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will delve into the significance of combined physical and behavioral health treatments on patient outcomes and discuss the key components of evidence-based integrated behavioral health models. Participants will also examine hurdles to adopting these integrated models, including systemic and cultural barriers, to better enable them to advocate for and navigate the provision of whole-person health care.
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join us to explore the role of personalized medicine in the management of inflammatory bowel disease (IBD), including the genetic and environmental factors that contribute to this disease. The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) framework of evidence- and consensus-based recommendations for IBD treatment strategies will be reviewed, and the significance of biomarkers in guiding individualized therapy will be highlighted, with a focus on emerging therapies such as JAK inhibitors and S1P receptor modulators.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will delve into the genetic predispositions and environmental factors contributing to the formation of aortic aneurysms (AA) and how these insights are leading to personalized treatment strategies. It will focus on advancements in screening, diagnosis and treatment, including ongoing research into new therapies such as intravenous immune-modulating cells that can potentially reduce aneurysm size.
  • Disease management
  • Older adults
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance
  • 0.50 ASWB - Social Workers
$0.00
The process of advanced care planning (ACP) is widely recognized as a method to support patient self-determination, facilitate decision-making and promote better care. The responsibilities of the clinician are to utilize diagnostic tests, observe vital signs, diagnose illness, administer treatment, provide a prognosis based on treatment progress and document the patient's medical history. ACP will not succeed without effective communication between clinicians and patients, as well as family members and caregivers as appropriate. Existing barriers when engaging patients in ACP may be challenging for health care professionals. This activity will describe the role of the clinician in ACP, identify existing barriers and discuss how to overcome those barriers.
  • Disease management
  • Pharmacy benefit management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to equip primary care providers with the knowledge and skills necessary to effectively implement deprescribing practices. It will discuss the challenges of problematic polypharmacy and identify strategies for recognizing deprescribing opportunities, as well as describe the role of governance strategies in deprescribing initiatives. Deprescribing, the process of tapering or stopping medications that may no longer be beneficial or may be causing harm, is crucial for improving patient outcomes and enhancing quality of life.

Pages